Hartford Healthcare
Hartford, Connecticut 06106
17 studies enrolling now · 40 studies all time
What they study most
Acute Myeloid Leukemia, Acute Stroke, Advanced Cancer, Advanced Melanoma, Advanced Solid Tumor, Alcohol Use Disorder, Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), Atypical Parkinsonism, Bipolar 1 Disorder, Bladder Cancer
Studies at this site
- fMRI and Opioid Abstinence — Recruiting now
- Assessment of CCM in HF With Higher Ejection Fraction — Recruiting now
- Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery — Recruiting now
- Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) — Recruiting now
- A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer — Recruiting now
- A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors — Recruiting now
- A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) — Recruiting now
- Medtronic Terminate AF Study — Recruiting now
- CLOZAPINE Response in Biotype-1 — Recruiting now
- Serranator POINT FORCE Registry — Recruiting now
- A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors — Recruiting now
- Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease — Recruiting now
- Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE) — Recruiting now
- rTMS as Add on Treatment for Substance Use Disorders — Recruiting now
- Parkinson's Foundation PD GENEration Genetic Registry — Recruiting now
- Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure — Recruiting now
- A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors — Running, not enrolling
- Targeting Fronto-Striatal Neural Circuitry Using Repetitive Transcranial Magnetic Stimulation to Reduce Irritability — Running, not enrolling
- Trial of Parkinson's And Zoledronic Acid — Completed
- CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma — Stopped early
- Assessment of Combined CCM and ICD Device in HFrEF — Running, not enrolling
- Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial — Running, not enrolling
- A Registry for Patients With Multifocal Ground Glass Opacities (GGOs) — Running, not enrolling
- IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry — Enrolling by invitation
- Pilot Trial of Mobile Technology for Adolescent Suicidality — Enrolling by invitation
- AMP SCZ® Observational Study: PREDICT-DPACC — Running, not enrolling
- Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors — Stopped early
- CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma — Stopped early
- Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation — Completed
- Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) — Stopped early
- Artoss Prospective Spine Registry Outcomes — Running, not enrolling
- Surveillance AFter Extremity Tumor surgerY — Running, not enrolling
- Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) — Running, not enrolling
- Blood Pressure After Endovascular Stroke Therapy-II — Completed
- A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) — Completed
- DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry — Status unconfirmed
- CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596) — Status unconfirmed
- Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer — Status unconfirmed
- Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC — Stopped early
- Drug Resistance Factors In Healthcare-associated Pneumonia — Completed